A detailed history of Ntv Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ntv Asset Management LLC holds 38,199 shares of ABBV stock, worth $6.55 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
38,199
Previous 37,823 0.99%
Holding current value
$6.55 Million
Previous $5.86 Million 18.68%
% of portfolio
1.08%
Previous 1.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $60,092 - $68,469
376 Added 0.99%
38,199 $6.96 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $718,134 - $808,788
-5,219 Reduced 12.13%
37,823 $5.86 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $9,351 - $10,825
70 Added 0.16%
43,042 $6.42 Million
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $14,311 - $17,809
-108 Reduced 0.25%
42,972 $5.79 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $19,377 - $22,316
134 Added 0.31%
43,080 $6.87 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $17,150 - $20,567
124 Added 0.29%
42,946 $6.94 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $2,147 - $2,462
-16 Reduced 0.04%
42,822 $5.75 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $21,743 - $27,643
-158 Reduced 0.37%
42,838 $6.56 Million
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $2,903 - $3,602
22 Added 0.05%
42,996 $6.97 Million
Q4 2021

Feb 04, 2022

SELL
$107.43 - $135.93 $126,337 - $159,853
-1,176 Reduced 2.66%
42,974 $5.82 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $60,648 - $68,844
570 Added 1.31%
44,150 $4.76 Million
Q2 2021

Aug 09, 2021

SELL
$105.21 - $117.21 $4,944 - $5,508
-47 Reduced 0.11%
43,580 $4.91 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $43,784 - $48,201
428 Added 0.99%
43,627 $4.72 Million
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $20,363 - $27,493
253 Added 0.59%
43,199 $4.63 Million
Q3 2020

Oct 29, 2020

BUY
$85.91 - $100.83 $2,061 - $2,419
24 Added 0.06%
42,946 $3.76 Million
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $281,960 - $377,305
3,843 Added 9.83%
42,922 $4.21 Million
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $140,674 - $213,279
2,181 Added 5.91%
39,079 $2.98 Million
Q4 2019

Jan 30, 2020

SELL
$72.13 - $90.25 $4,904 - $6,137
-68 Reduced 0.18%
36,898 $3.27 Million
Q3 2019

Nov 04, 2019

BUY
$62.98 - $75.72 $9,698 - $11,660
154 Added 0.42%
36,966 $2.8 Million
Q2 2019

Jul 29, 2019

BUY
$65.7 - $83.98 $676,907 - $865,245
10,303 Added 38.87%
36,812 $2.68 Million
Q1 2019

Apr 29, 2019

BUY
$77.14 - $90.79 $35,021 - $41,218
454 Added 1.74%
26,509 $2.14 Million
Q4 2018

Jan 28, 2019

SELL
$77.85 - $96.01 $62,124 - $76,615
-798 Reduced 2.97%
26,055 $2.4 Million
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $44,188 - $49,123
-497 Reduced 1.82%
26,853 $2.54 Million
Q2 2018

Aug 06, 2018

BUY
$89.78 - $106.23 $4,668 - $5,523
52 Added 0.19%
27,350 $2.53 Million
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $9,108 - $12,197
-99 Reduced 0.36%
27,298 $2.58 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $33,405 - $36,632
-373 Reduced 1.34%
27,397 $2.65 Million
Q3 2017

Nov 06, 2017

SELL
$69.85 - $89.22 $373,138 - $476,613
-5,342 Reduced 16.13%
27,770 $2.47 Million
Q2 2017

Aug 08, 2017

BUY
N/A
33,112
33,112 $2.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ntv Asset Management LLC Portfolio

Follow Ntv Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntv Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ntv Asset Management LLC with notifications on news.